Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AR-17043 by Alcon for Ocular Hypertension: Likelihood of Approval
AR-17043 is under clinical development by Alcon and currently in Phase II for Ocular Hypertension. According to GlobalData, Phase II...